Study of the SCD411 Prefilled Syringe for Treating Adults With Wet Age-Related Macular Degeneration, Retinal Vein Occlusion, Diabetic Macular Edema, or Diabetic Retinopathy

Part of paid clinical trials in Stuart, Florida.

Sponsor
Sam Chun Dang Pharm. Co. Ltd.
Study ID
NCT07501052
Phase
PHASE2
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • SCD411 0.05mL (2mg) — DRUG
    Single intravitreal therapy (IVT) injection using a prefilled syringe (PFS)

Study Details

This is a single-arm, multicenter study to evaluate clinical usability of a pre-filled syringe containing SCD411 in adult patients with neovascular Wet Age-Related Macular Degeneration (AMD), Retinal Vein Occlusion (RVO), Diabetic Macular Edema (DME), or Diabetic Retinopathy (DR)

Key Dates

Start date
May 13, 2026
Status verified
Jun 2026
Primary completion
May 27, 2026
Completion
Jun 1, 2026

Study Design

Enrollment
33 participants (actual)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: SCD411

Primary Outcome Measure

Percentage of successful task completions for product use tasks (from opening the carton to disposal of the used PFS and needle) [ Time Frame: Baseline [Day 1] ]

Locations (4)

FacilityCityStateZIPSite coordinators
East Florida Eye InstituteStuartFlorida34994-
Center for Retina and Macular DiseaseWinter HavenFlorida33880-
University Retina & Macula Associates, P.CLemontIllinois60439-
Retina Vitreous Surgeons of Central New York, PCLiverpoolNew York13088-

Find similar trials in Stuart, FL

By condition
Diabetic retinopathy
By specialty
OphthalmologyRetina
By research site
East Florida Eye Institute· Stuart, FLCenter for Retina and Macular Disease· Winter Haven, FLUniversity Retina & Macula Associates, P.C· Lemont, ILRetina Vitreous Surgeons of Central New York, PC· Liverpool, NY

Related Studies